Document Type : Review article
Authors
1
Faculty of Pharmacy, Cyprus International University, Nicosia, Cyprus (Via Mersin 10)
2
Faculty of pharmacy, Cyprus International University, Nicosia, Cyprus, Via Mersin 10
Abstract
Cancer continues to represent a formidable global health challenge, underscoring the urgent need for the development of cost-effective therapeutic strategies. The design of nanomedicines with precise targeting capability and enhanced bioavailability opens new opportunities in cancer therapy. Among all the nanoplatforms, plant-derived nanoparticles have attracted more attention because of their excellent biodegradability, biocompatibility, and low cytotoxicity. Bio-inspired nanocarriers use the abundance of phytochemical diversity present in medicinal plants to target multi-pathway signaling and counteract resistance mechanisms of cancer. The utilization of bioactive compounds from plants, including flavonoids, alkaloids, and polyphenols, leads to increased anti-cancer activity with fewer side effects. While these features are promising, there are several challenges to be overcome for successful clinical outcomes (stability, large-scale production, controlled drug release, etc.). Herein, different innovations are discussed related to plant-based nanomedicines, particularly in the context of sustainable and effective anti-cancer therapy. The ability of plant-based nanoparticles to modulate multiple cellular pathways represents a key advantage, as it can disrupt cancer progression and resistance mechanisms. What makes phytochemicals ideal candidates for targeted cancer therapies is that they naturally possess unique properties such as antioxidant, anti-inflammatory, and pro-apoptotic. Furthermore, Inhibition of tumor growth, suppression of metastasis, and enhanced immune responses, which will contribute to comprehensive cancer control, are achievable by the use of these plant-based bioactive compounds. Furthermore, the inherent biodegradability of plant-derived nanoparticles minimizes long-term toxicity concerns, aligning with the principles of sustainable medicine. Integrating nanotechnology with nature-originated therapeutic agents for producing plant-derived nanomedicines shows huge prospects in reshaping cancer treatment paradigms. This review highlights the confluence of phytochemicals and nanotechnology, focusing on novel formulations that target precision and patient care in cancer.
Highlights
-
Plant-derived nanomedicines offer safe, biocompatible cancer therapy.
-
Phytochemicals in nanoparticles target multiple cancer pathways effectively.
-
PDNPs show natural biodegradability, reducing chronic toxicity risks.
-
Plant nanovesicles overcome drug resistance and modulate tumor immunity.
-
Sustainable plant sources enable green, scalable nanomedicine production.
Keywords